1. Market Research
  2. > Gambro Medical Device Company Intelligence Report

Gambro Medical Device Company Intelligence Report

  • February 2013
  • -
  • Espicom Business Intelligence
  • -
  • 22 pages

Gambro was founded in 1964 and has approximately 7,500 employees, 13 production facilities in nine countries and sales subsidiaries in more than 100 countries.

Sweden's Wallenberg family controls Gambro through its Investor AB investment firm. In June 2006, the family took over Gambro from the Stockholm Stock Exchange, in a transaction valued at approximately US$5.4 billion. The Wallenbergs previously owned 19.9% of the company before they made the purchase with EQT Partners, a Stockholm-based buyout firm partly-owned by Investor AB. As at January 2013, EQT Partners owned 51% of Gambro and Investor AB held the remaining 49% (Investor AB also owns 10% of Gambro through its investment in EQT). Gambro represents 3% of Investor AB’s total assets.

In December 2004, Gambro sold its US healthcare clinics to rival DaVita for US$3.1 billion.

In November 2006, Gambro's businesses were split into three independent businesses: Gambro Renal Products, to make products for dialysis machines and provide blood purification for hospital intensive care units; Gambro BCT, to sell blood collection and separation equipment; and Gambro Healthcare, to operate healthcare facilities in Europe, South America, Asia and Australia. Gambro Renal Products subsequently became the new Gambro AB, while Gambro BCT changed its name to CaridianBCT. In May 2007, Gambro Healthcare was sold to Bridgepoint, a European private equity firm, and is now known as Diaverum; and, in April 2011, CaridianBCT was sold to Terumo Corporation for US$2.63 billion.

In May 2011, Gambro moved its corporate headquarters from Stockholm to Lund, citing that the move will lead to improved cross-functional collaboration and efficiency improvements. The majority of Gambro’s functions, including sales and marketing, R&D and manufacturing, are present at Gambro’s Lund site, which has approximately 800 employees. The Stockholm office closed at the end of 2011.

In December 2012, Investor AB and EQT entered into a definitive agreement to sell Gambro to Baxter International, for total consideration of SKr 26.5 billion (approximately US$4.0 billion). With a broad and complementary dialysis product portfolio, Baxter can accelerate product sales in established markets such as Europe, where Gambro has an extensive footprint. Baxter could also expand Gambro's reach in high-growth regions of Latin America and Asia-Pacific, where Baxter has steadily grown its peritoneal dialysis business.

Within the healthcare industry, Investor also owns Mölnlycke Health Care, a provider of single-use surgical and wound care products and services; and Aleris, a Scandinavian healthcare and care service provider. EQT owns Dako Denmark, which undertakes medical tests used to diagnose cancer.

Table Of Contents

Gambro Medical Device Company Intelligence Report


Key Facts 1
The Swedish Healthcare Landscape 2


2011-2012 Achievements 3
Baxter Acquisition 3
Espicom View 3


2011 Financial Results . 4
Key Financial Highlights 2011 4
Outlook . 5
Employees 5


Chronic 6
Haemodialysis 6
Peritoneal Dialysis .7
Myeloma Kidney Therapy .7
Acute Therapies 8
Ventures Division . 9
Vascular Access .9
Water Systems 9


RandD Agreements .10
Novalung 10
Studies and Trials .10
Investigation into Chronic Inflammation in ESRD Patients 10
Early initiation may have contributed to excellent outcomes 12
Study emphasises importance of assessing delivery of prescribed CRRT dose 12



Medisystems 14
Source Medical (now Cardinal Health Canada) .14
Dipylon Medical .15
Debiotech 15
DaVita 15
Baxter International 15


Baxter International 16
CHF Solutions 16
Hemapure .17
Teraklin .17


CaridianBCT .18
Sale of PD Business .18
US Water Business 18
Blood Line Manufacturing Facility in Italy 18
Gambro Healthcare 19
Gambro Healthcare US .19
Thoratec .19
Point Therapeutics .19
Scandinavian Heart Center .19


Fresenius Medical Care 21


List of tabLes

Recent Key Events 2
Gambro - Annual Financial Data, 2007-2011 .4
Gambro's 2011 Market Position by Major Product Groups .6
Gambro - Principal Manufacturing Operations, January 2013 13
Agreements Summary .14
Mergers and Acquisitions Summary 16

List of Charts

Gambro - Annual Sales and Normalised EBITDA, 2011 .4
Gambro - HD Products Market Share, 2011 .6

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.